COVID-19 Clinical Trials

A listing of COVID-19 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 80 clinical trials
PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

COVID-19 (novel coronavirus-induced disease) was declared a global pandemic by the WHO on 11th March 2020. Currently there are no drugs proven to prevent COVID-19 or to reduce the severity of

  • 0 views
  • 11 May, 2021
  • 1 location
Honey and Nigella Sativa in COVID-19 Prophylaxis

Honey and Nigella sativa has established antiviral, antibacterial, anti-inflammatory, and immunomodulatory roles. So it is planned to test for its prophylaxis

  • 0 views
  • 02 Mar, 2021
  • 1 location
Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control Randomized Clinical Trial

The aim of this study is to evaluate the efficacy and safety of Mefloquine as a prophylaxis against SARS-Cov-2 infection in household contacts of COVID 19 confirmed. This study is an open-label

  • 0 views
  • 30 Apr, 2021
  • 1 location
The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19

The study is a multicenter, adaptive, randomized, double-blinded and placebo-controlled Phase II/III trial, and will be conducted globally. The study is comprised of two parts: dose selection (Phase II) and pivotal treatment effect (Phase III).

  • 0 views
  • 21 Apr, 2021
  • 7 locations
Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

This study aims to evaluate the safety, tolerability and efficacy of molnupiravir (MK-4482) compared to placebo. The primary hypothesis is that molnupiravir is superior to placebo as assessed by the percentage of participants who are hospitalized and/or die through Day 29

  • 0 views
  • 19 Jun, 2021
  • 112 locations
Anti COVID 19 Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients

of patients in Clinical Trial phase II/III. One Group will receive 0.15g/kg single dose of anti COVID 19 intravenously immunoglobulin (C-IVIG) develop from convalescent plasma of recovered patients

  • 0 views
  • 24 May, 2021
  • 1 location
Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients

At least 1 in 6 COVID-19 patients admitted to hospital to receive extra oxygen will die of complications. In patients with COVID-19, invasive treatment such as mechanical ventilation (e.g

  • 0 views
  • 30 Apr, 2021
  • 1 location
Efficacy of Nafamostat in Covid-19 Patients (RACONA Study)

RACONA is a prospective trial that will test the hypothesis that nafamostat can lower lung function deterioration and need for intensive care admission in COVID-19 patients. Design: Adult

  • 0 views
  • 19 Jun, 2021
  • 1 location
Upamostat a Serine Protease Inhibitor or Placebo for Treatment of COVID-19 Disease

A 2-part, multicenter, Phase 2/3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of upamostat in adult patients with COVID-19 disease who

  • 0 views
  • 25 Apr, 2021
  • 7 locations
The Safety and Efficacy of Pyronaridine-artesunate (Pyramax or Artecom )in COVID-19 Patients

This is a multi-center, randomized, Phase 2/3 study to evaluate the safety and efficacy of pyronaridine-artesunate in participants with corona virus disease 2019 (COVID-19). Pyronaridine

  • 0 views
  • 06 Apr, 2021
  • 2 locations